PCK1 overexpression accelerates colorectal xenograft growth [25] but also antagonizes hepatoma proliferation [26], suggesting contextual roles of PCK1 for a given tumor type and metabolic stress, and G6PC protects glioblastoma cells from 2-deoxyglucose (2DG) treatment [27]. The gene discussed is PCK1; the disease is neoplasm.